Search Results - "Skelly, B.J"

Systematic Review of Prognostic Factors for Mortality in Dogs with Immune‐mediated Hemolytic Anemia by Swann, J.W., Skelly, B.J.

“…Background Treatment of dogs with primary immune‐mediated hemolytic anemia (IMHA) is difficult and frequently unrewarding. Prognostic factors have been…”
Get full text

Systematic Review of Evidence Relating to the Treatment of Immune-Mediated Hemolytic Anemia in Dogs by Swann, J.W., Skelly, B.J.

“…Despite being the most prevalent autoimmune disease of dogs, there is considerable variation between individuals and institutions in the treatment regimens…”
Get full text

Evaluation of immunosuppressive regimens for immune-mediated haemolytic anaemia: a retrospective study of 42 dogs by Swann, J.W, Skelly, B.J

“…Objectives: Immune-mediated haemolytic anaemia (IMHA) is a severe disease for which evidence is lacking to make informed choices regarding immunosuppressive…”
Get full text

Risk of vomiting and diarrhoea in dogs by Hubbard, K., Skelly, B. J., McKelvie, J., Wood, J. L. N.

Get full text

Management of 13 cases of canine respiratory disease using inhaled corticosteroids by Bexfield, N.H, Foale, R.D, Davison, L.J, Watson, P.J, Skelly, B.J, Herrtage, M.E

“…To determine the value of inhaled corticosteroids in the management of chronic inflammatory airway disease in dogs. Medical records of dogs that were presented…”
Get full text

Mutations in genes causing human familial isolated hyperparathyroidism do not account for hyperparathyroidism in Keeshond dogs by Skelly, Barbara J., Franklin, Robin J.M.

“…The roles of the calcium sensing receptor gene (CaSR) and the multiple endocrine neoplasia gene (MEN1) were investigated in Keeshond dogs with familial…”
Get full text

Use of trilostane for the treatment of pituitary-dependent hyperadrenocorticism in a cat by Skelly, B.J, Petrus, D, Nicholls, P.K

“…Hyperadrenocorticism occurs much less frequently in cats than in dogs and, at present, is more difficult to manage successfully. This report documents the use…”
Get full text

Eprinomectin: A novel avermectin for use as a topical endectocide for cattle by Shoop, W.L., Egerton, J.R., Eary, C.H., Haines, H.W., Michael, B.F., Mrozik, H., Eskola, P., Fisher, M.H., Slayton, L., Ostlind, D.A., Skelly, B.J., Fulton, R.K., Barth, D., Costa, S., Gregory, L.M., Campbell, W.C., Seward, R.L., Turner, M.J.

“…Eprinomectin (MK-397 or 4″-epi-acetylamino-4″-deoxy-avermectin B 1) is a novel avermectin selected for development as a topical endectocide for all cattle,…”
Get full text

Survey of pharmacists’ awareness of veterinary medicines by Monie, O. R., Bryant, C. E., Skelly, B. J.

“…A survey of 186 pharmacies across Great Britain in 2004 showed that the pharmacists had little involvement in the supply of veterinary medicines. Most of them…”
Get full text

Efficacy in sheep and pharmacokinetics in cattle that led to the selection of eprinomectin as a topical endectocide for cattle by Shoop, W.L., Demontigny, P., Fink, D.W., Williams, J.B., Egerton, J.R., Mrozik, H., Fisher, M.H., Skelly, B.J., Turner, M.J.

“…Eprinomectin (MK-397 or 4″-epi-acetylamino-4″-deoxy-avermectin B 1) is a novel avermectin selected for development as a topical endectocide for all cattle,…”
Get full text

Identification of a 6 base pair insertion in West Highland White Terriers with erythrocyte pyruvate kinase deficiency by Skelly, B J, Wallace, M, Rajpurohit, Y R, Wang, P, Giger, U

“…To define the disease-causing mutation in West Highland White Terriers (WHWT) with erythrocyte pyruvate kinase (R-PK) deficiency and to design a genetic test…”
Get more information

Pharmacokinetics of [3H]-ivermectin in the dog following oral administration of a beef-based chewable formulation containing ivermectin alone or in combination with pyrantel pamoate by Clark, J N, Daurio, C P, Skelly, B J, Cheung, E N, Jeffcoat, A R

Get more information